Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Sienna+MR Long-term Uptake
The document reports the completed status of a clinical trial evaluating long-term uptake of Sienna+MR in female breast cancer patients.
-
FDA approval · 2017-08-09FDA Approved: DOCETAXEL — Original Application (Jiangsu Hengrui Pharmaceuticals Co., Ltd.)
FDA approved a generic version of docetaxel under an original ANDA from Jiangsu Hengrui Pharmaceuticals Co., Ltd., enabling market authoriza…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors [NA]
A completed clinical trial investigated whether omega-3 fatty acid supplementation reduces cancer-related fatigue in breast cancer survivors…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
This completed clinical trial update reports on chemotherapy decision-making and outcomes in older women with newly diagnosed breast cancer.
-
CLINICAL_TRIALS research · 2017-08-08Clinical Trial Update: Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741
A completed study update focusing on tissue samples from women treated with paclitaxel for breast cancer in the CALGB-9344 and CALGB-9741 tr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-08-08Clinical Trial Update: Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer
This clinical trial update reports completion of a study examining gene expression profiling and genetic analysis of tissues from patients w…
-
CLINICAL_TRIALS research · 2017-08-07Clinical Trial Update: Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience
A clinical trial update describing the Salah Azaïz Cancer Institute's experience with male breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment [Phase 1, Phase 2]
Clinical trial update for ONTAK in advanced breast cancer patients who failed prior therapy, spanning Phase 1 and Phase 2, with completed st…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Phase II Study for Solid Metastatic Tumors [Phase 2]
Phase II study for solid metastatic tumors has completed, focusing on breast cancer and metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Eradication of Malignant Carcinoma in the Breast Tissue [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials evaluating eradication of malignant carcinoma in breast tissue have completed. Sponsor: Optimal Health R…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: FNA Tumor Sampling for CD137 Modulation: A Pilot Study
Termination update for a pilot study evaluating FNA tumor sampling for CD137 modulation in cancer patients.
-
CLINICAL_TRIALS research · 2017-08-03Clinical Trial Update: Tissue Stresses of Cancer (Force Horizon 2020) [Phase 1, Phase 2]
An early-phase clinical trial update for the Tissue Stresses of Cancer study (Force Horizon 2020) led by Guy's and St Thomas' NHS Foundation…
-
FDA approval · 2017-08-03FDA Approved: GEMCITABINE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's gemcitabine injectable drug as an original application, providing a generic version of the anticancer agent…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE) [Phase 2]
Phase 2 GENEVIEVE trial comparing cabazitaxel to weekly paclitaxel as neoadjuvant therapy in specific breast cancer subtypes to assess effic…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy [Phase 2]
A Phase 2 trial comparing palbociclib alone versus in combination with endocrine therapy for reversing endocrine resistance in breast cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes [Phase 2]
Phase 2 clinical trial evaluating cabazitaxel in metastatic breast cancer patients previously treated with taxanes has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Study of Artesunate in Metastatic Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluating artesunate in metastatic breast cancer and locally advanced breast cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer [Phase 2]
Phase 2 trial of MK-2206 in breast cancer was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating ZD1839 (Iressa) in combination with Tamoxifen for breast cancer was terminated.
-
CLINICAL_TRIALS research · 2017-08-01Clinical Trial Update: Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
Completed clinical trial update describing a study that collects urine and blood samples from women with newly diagnosed breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Update on a Wake Forest University Health Sciences trial evaluating tamoxifen resistance in women with Stage I, II, IIIA, or IIIB breast can…
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating multimodality treatment for women with Stage II to Stage IV breast cancer; results posted in 2017.
-
CLINICAL_TRIALS research · 2017-07-28Clinical Trial Update: A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin [Phase 2, Phase 3]
This document provides an update on a randomized controlled trial comparing lapatinib versus trastuzumab for HER2-positive breast cancer in …
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging [Phase 2]
Phase 2 trial assessing MRI for early detection of trastuzumab-related cardiac toxicity in breast cancer patients; the study has been termin…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer [NA]
Clinical trial update on TOBI to monitor response to neoadjuvant therapy in breast cancer. The study status is completed.